Related Experiment Videos

CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary

D S Franklin1, V L Godfrey, H Lee

  • 1Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.

Genes & Development
|September 23, 1998
PubMed

Insights

Mice lacking the p18 (INK4c) protein inhibitor developed gigantism and pituitary tumors. P18 and p27 collaboratively suppress pituitary tumor growth, highlighting their roles in cell cycle regulation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Cyclin-dependent kinase (CDK) inhibitors regulate cell growth.
  • INK4 and CIP/KIP are two main families of CDK inhibitors.
  • These inhibitors are crucial for controlling cell proliferation signals.

Purpose of the Study:

  • To investigate the role of p18 (INK4c) in cell growth and tumor suppression.
  • To understand the collaborative function of p18 and p27 in preventing pituitary tumorigenesis.

Main Methods:

  • Generation of p18 (INK4c)-deficient mice.
  • Analysis of organ size, cellularity, and proliferation rates in knockout mice.
  • Comparative study of mice lacking p18, p27, or both.

Main Results:

  • p18-deficient mice exhibited gigantism and organomegaly, particularly in the pituitary, spleen, and thymus.
  • Loss of p18 led to pituitary hyperplasia progressing to adenoma with high penetrance.
  • Mice lacking both p18 and p27 died early from pituitary adenomas.

Conclusions:

  • p18 (INK4c) is essential for suppressing pituitary tumor development.
  • p18 and p27 act through separate pathways to collaboratively inhibit pituitary tumorigenesis.
  • These CDK inhibitors likely control the function of Rb to prevent tumor formation.

Related Concept Videos